SCHEMBL22323745

SCHEMBL22323745

COCOc1cc2cc(C(=O)N(C)C)oc2cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.41
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TP53 P04637 1/20 0.36
CYP1A2 P05177 2/20 0.35
MAPT P10636 2/20 0.35
CYP2C19 P33261 1/20 0.35
OXTR P30559 2/20 0.35
NCEH1 Q6PIU2 1/20 0.35
ALDH1A1 P00352 3/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29509324 1.00 LRRK2 (0.41) LRRK2LMNASMN1; SMN2MEN1KMT2A
SCHEMBL28686553 0.86 LMNA (0.50) LMNASMN1; SMN2MEN1KMT2ATP53
SCHEMBL29509339 0.86 LMNA (0.50) LMNASMN1; SMN2MEN1KMT2ATP53
SCHEMBL22323782 0.85 LRRK2 (0.47) LRRK2LMNASMN1; SMN2MEN1KMT2A
SCHEMBL22323632 0.78 LRRK2 (0.37) LRRK2LMNASMN1; SMN2MEN1KMT2A
SCHEMBL29381363 0.78 LRRK2 (0.37) LRRK2LMNASMN1; SMN2MEN1KMT2A
SCHEMBL29380889 0.77 OXTR (0.51) LMNATP53OXTRALDH1A1HPGD
SCHEMBL15005979 0.73 LRRK2 (0.47) LRRK2LMNASMN1; SMN2MEN1KMT2A
SCHEMBL22324030 0.71 LRRK2 (0.38) LRRK2LMNASMN1; SMN2MEN1KMT2A
SCHEMBL19147152 0.70 GPR35 (0.41) SMN1; SMN2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3920917-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING Skyhawk Therapeutics, Inc. (US) 2021-12-15 EP disclosed
WO-2020163248-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. (US) 2020-08-13 WO disclosed